Ligelizumab for Chronic Spontaneous Urticaria

Affiliations

Comment

Miles Weinberger. N Engl J Med. 2020.

. 2020 Feb 6;382(6):579.

doi: 10.1056/NEJMc1915041.

¹ University of California, San Diego, San Diego, CA miles-weinberger@uiowa.edu.

No abstract available

Comment in

Ligelizumab for Chronic Spontaneous Urticaria. Reply.
Maurer M, Giménez-Arnau AM, Metz M. Maurer M, et al. N Engl J Med. 2020 Feb 6;382(6):579-580. doi: 10.1056/NEJMc1915041. N Engl J Med. 2020. PMID: 32023386 No abstract available.
Ligelizumab for Chronic Spontaneous Urticaria. Reply.
Center DM. Center DM. N Engl J Med. 2020 Feb 6;382(6):580. doi: 10.1056/NEJMc1915041. N Engl J Med. 2020. PMID: 32023387 No abstract available.

Ligelizumab for Chronic Spontaneous Urticaria.
Maurer M, Giménez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, Bernstein JA, Brehler R, Chu CY, Chung WH, Danilycheva I, Grattan C, Hébert J, Katelaris C, Makris M, Meshkova R, Savic S, Sinclair R, Sitz K, Staubach P, Wedi B, Löffler J, Barve A, Kobayashi K, Hua E, Severin T, Janocha R. Maurer M, et al. N Engl J Med. 2019 Oct 3;381(14):1321-1332. doi: 10.1056/NEJMoa1900408. N Engl J Med. 2019. PMID: 31577874 Clinical Trial.
A Better IgE Trap to Control Urticaria.
Center DM. Center DM. N Engl J Med. 2019 Oct 3;381(14):1376-1377. doi: 10.1056/NEJMe1907122. N Engl J Med. 2019. PMID: 31577881 No abstract available.